The Heart Hospital Imaging Centre, University College London Hospitals Trust, 16 Westmoreland Street, London, UK.
Br J Radiol. 2011 Dec;84 Spec No 3(Spec Iss 3):S296-305. doi: 10.1259/bjr/67212179.
Cardiomyopathies (CMPs) are a group of often inherited diseases characterised by abnormalities and associated dysfunction of heart muscle. In the past decade, cardiovascular magnetic resonance (CMR) has emerged as a powerful tool in their assessment, providing data that are complementary to other aspects of clinical evaluation. Key advantages of CMR are three-dimensional visualisation of the heart and its relationship to thoracic structures; gold-standard quantification of cardiac volumes and function, which can safely be repeated over time (no ionising radiation is involved); and tissue characterisation to detect focal scar and fatty infiltration. This paper reviews the role of CMR in the clinical assessment of patients with CMPs.
心肌病(CMPs)是一组常染色体遗传性疾病,其特征为心肌异常和相关功能障碍。在过去十年中,心血管磁共振(CMR)已成为评估这些疾病的有力工具,提供了与临床评估其他方面互补的数据。CMR 的主要优势在于能够三维可视化心脏及其与胸部结构的关系;能够安全地重复进行心脏容积和功能的金标准定量,且无放射性(不涉及电离辐射);以及能够进行组织特征分析以检测局灶性瘢痕和脂肪浸润。本文综述了 CMR 在 CMP 患者临床评估中的作用。